Three ileus cases associated with the use of dipeptidyl peptidase-4 inhibitors in diabetic patients

Journal of Diabetes Investigation

Volumn 4, Issue 6, 2013, Pages 673-675

  Kanasaki, Keizo ^a   Konishi, Kazunori ^a   Hayashi, Ranji ^a   Shiroeda, Hisakazu ^a   Nomura, Tomoe ^a   Nakagawa, Atsushi ^a   Nagai, Takako ^a   Takeda Watanabe, Ai ^a   Ito, Hiroki ^a   Tsuda, Shin ichi ^a   Kitada, Munehiro ^a   Fujii, Mizue ^a   Kanasaki, Megumi ^a   Nishizawa, Makoto ^a   Nakano, Yasuharu ^a   Tomita, Yasuto ^a   Ueda, Nobuhiko ^a   Kosaka, Takeo ^a   Koya, Daisuke ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Adverse drug reaction; Complication; Dipeptidyl peptidase 4; Niveau

Indexed keywords

ALISKIREN; ALOGLIPTIN; AMLODIPINE; CAMOSTAT MESILATE; CARBIDOPA PLUS LEVODOPA; DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV INHIBITOR; INSULIN GLARGINE; LIVER EXTRACT; METFORMIN; MIGLITOL; MITIGLINIDE; MOSAPRIDE; POLYSTYRENESULFONATE CALCIUM; PREDNISOLONE; REPAGLINIDE; SITAGLIPTIN; VILDAGLIPTIN;

ABDOMINAL PAIN; ABDOMINAL RADIOGRAPHY; ADD ON THERAPY; ADULT; ADVERSE DRUG REACTION; AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEFECATION; DIABETES MELLITUS; DIABETIC PATIENT; DIARRHEA; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG MECHANISM; DRUG SAFETY; DRUG SUBSTITUTION; DRUG USE; DRUG WITHDRAWAL; ENZYME INHIBITION; FEMALE; HUMAN; ILEUS; MALE; MEDICAL HISTORY; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; PARKINSON DISEASE; PRIORITY JOURNAL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; VOMITING;

EID: 84888430746     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/jdi.12095     Document Type: Article

References (10)

1. Drucker DJ. The biology of incretin hormones. Cell Metab 2006; 3: 153-165.
2. Marathe CS, Rayner CK, Jones KL, Horowitz M. Effects of GLP-1 and incretin-based therapies on gastrointestinal motor function. Exp Diabetes Res 2011; 2011: 279530.
3. Cernea S, Raz I. Therapy in the early stage: incretins. Diabetes Care 2011; 34(Suppl. 2): S264-S271.
4. Kashiwagi A, Kasuga M, Araki E, et al. International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Invest 2012; 3: 39-40.
5. Rizzo MR, Barbieri M, Marfella R, Paolisso G. Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition. Diabetes Care 2012; 35: 2076-2082.
6. Scheen AJ. Pharmacokinetics of dipeptidylpeptidase-4 inhibitors. Diabetes Obes Metab 2010; 12: 648-658.
7. Varbanova M, Schütte K, Kuester D, et al. [Acute abdomen in a patient with ANCA-associated vasculitis.] Dtsch Med Wochenschr 2011; 136: 1783-1787 (German).
8. Andrews CN, Storr M. The pathophysiology of chronic constipation. Can J Gastroenterol 2011; 25(Suppl. B): 16B-21B.
9. Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol 2003; 2: 107-116.
10. Fehmann HC, Goke R, Goke B. Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. Endocr Rev 1995; 16: 390-410.